智飞生物：冻干水痘灭活疫苗获得临床试验批准通知书

Core Viewpoint - The announcement indicates that Zhifei Biological's subsidiary has received approval for clinical trials of a freeze-dried varicella inactivated vaccine aimed at preventing varicella-zoster virus infections [1] Group 1 - Zhifei Biological's wholly-owned subsidiary, Anhui Zhifei Longkema Biological Pharmaceutical Co., Ltd., is responsible for the development of the vaccine [1] - The vaccine is intended to prevent infections caused by the varicella-zoster virus, which leads to chickenpox [1] - The approval was granted by the National Medical Products Administration, allowing the company to proceed with clinical trials [1]